Ivermectin reduces in vivo coronavirus infection in a mouse experimental model

The objective of this study was to test the effectiveness of ivermectin for the treatment of mouse hepatitis virus (MHV), a type 2 family RNA coronavirus similar to SARS-CoV-2. Female BALB/cJ mice were infected with 6,000 PFU of MHV-A59 (group infected, n = 20) or infected and then immediately treat...

Полное описание

Библиографические подробности

Главный автор:	Arévalo, Ana Paula (author)
Другие авторы:	Pagotto, Romina (author), Pórfido Barayoli, Jorge Luis (author), Daghero Villanueva, Hellen (author), Segovia, Mercedes (author), Yamasaki, Kanji (author), Varela Cruces, María Belén (author), Hill, Marcelo (author), Verdes García, José Manuel (author), Duhalde Vega, Maite (author), Bollati-Fogolín, Mariela (author), Crispo, Martina (author)
Формат:	article
Язык:	английский
Опубликовано:	2021
Предметы:	INFECCION EXPERIMENTAL RATONES IVERMECTINA CORONAVIRUS CAUSANTE DEL SINDROME RESPIRATORIO AGUDO SEVERO TERAPIA
Online-ссылка:	https://hdl.handle.net/20.500.12008/48337 https://doi.org/10.1038/s41598-021-86679-0
Метки:	Добавить метку Нет меток, Требуется 1-ая метка записи!